Related Experiment Video
Updated: Jun 15, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report
Maki Arakawa1, Kogenta Nakamura, Yoshiaki Yamada
1Department of Urology, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan.
Background:
Gefitinib remains an excellent treatment option for patients with a variety of cancers, including non small cell lung cancer (NSCLC). However, clinicians must be aware of the potential of gefitinib to cause an inflammatory reaction in the skin, lungs and bladder.
Case Presentation:
We present a case on hemorrhagic cystitis and severely contracted bladder in a patient with NSCLC on gefitinib.
Conclusions:
Further studies are needed to substantiate the association of gefitinib therapy with hemorrhagic cystitis and contracted bladder.
